262 research outputs found
The Role of Eicosapentaenoic Acid for Residual Cardiovascular Risk Despite Statin Therapy
Cardiovascular disease (CVD) was responsible for over 840,000 deaths in the United States in 2016 and costs an estimated $352 billion annually in both direct and indirect costs. Approximately every 40 seconds, an American will have an acute myocardial infarction (AMI), and at a similar rate an American will have a stroke. In patients who experienced AMI from 2010 to 2016, statin use at hospital discharge increased from 92% to 99%. Nonetheless, cardiovascular disease remains the leading cause of death in the United States and more than one million coronary events are expected to occur in individuals in 2019; approximately 335,000 of those cases will be recurrent coronary events. 1 Understanding the risk factors for CVD and then reducing those risks have the potential to decrease the impact of this disease
COMMODITY PROGRAMS AND RURAL REVITALIZATION
Community/Rural/Urban Development,
The Role of Eicosapentaenoic Acid for Residual Cardiovascular Risk Despite Statin Therapy
Cardiovascular disease (CVD) was responsible for over 840,000 deaths in the United States in 2016 and costs an estimated $352 billion annually in both direct and indirect costs. Approximately every 40 seconds, an American will have an acute myocardial infarction (AMI), and at a similar rate an American will have a stroke. In patients who experienced AMI from 2010 to 2016, statin use at hospital discharge increased from 92% to 99%. Nonetheless, cardiovascular disease remains the leading cause of death in the United States and more than one million coronary events are expected to occur in individuals in 2019; approximately 335,000 of those cases will be recurrent coronary events. 1 Understanding the risk factors for CVD and then reducing those risks have the potential to decrease the impact of this disease
Social/health maintenance organization and fee-for-service health outcomes over time.
Evaluating the performance of long-term care (LTC) demonstrations requires longitudinal assessment of multiple outcomes where selective mortality and disenrollment, if not accounted for, can give the appearance of reduced (or enhanced) efficacy. We assessed outcomes in social/health maintenance organizations (S/HMOs) and Medicare fee-for-service (FFS) care using a multivariate model to estimate active life expectancy (ALE). S/HMO enrollees and samples of FFS clients in four sites were analyzed and outcome differences assessed for a 3-year period. Results provide insights into S/HMO performance under different conditions and, more generally, into evaluating LTC demonstrations without randomized client and control groups
The Wasberg Effect
Working on demonstrations that were considered useful and graphic teaching tools received considerable energy from the participants at the North West Workshop for Teachers of Chemistry (NWW) under the direction of Dr. Glenn Crosby at Washington State University in 1987. Some new demonstrations were developed, but most of the effort was spent dealing with traditional and published successful teaching aids to make the directions uniform and clear, even to teachers without extensive chemistry training, and to perfect directions that would work every time
- …